These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36516818)

  • 1. The pathogenesis of rheumatoid arthritis.
    Alivernini S; Firestein GS; McInnes IB
    Immunity; 2022 Dec; 55(12):2255-2270. PubMed ID: 36516818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of Podoplanin in Synovial Tissues in Rheumatoid Arthritis Patients Using Biologic or Conventional Disease-Modifying Anti-Rheumatic Drugs.
    Takakubo Y; Oki H; Naganuma Y; Saski K; Sasaki A; Tamaki Y; Suran Y; Konta T; Takagi M
    Curr Rheumatol Rev; 2017; 13(1):72-78. PubMed ID: 27030253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of power Doppler synovitis in rheumatoid arthritis patients with synthetic and/or biological disease-modifying anti-rheumatic drug-induced clinical remission: experience from a Chinese cohort.
    Geng Y; Han J; Deng X; Zhang Z
    Clin Rheumatol; 2014 Aug; 33(8):1061-6. PubMed ID: 24777468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of rheumatoid arthritis: Unraveling the conundrum.
    Zampeli E; Vlachoyiannopoulos PG; Tzioufas AG
    J Autoimmun; 2015 Dec; 65():1-18. PubMed ID: 26515757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical synovitis measured by ultrasound in rheumatoid arthritis patients with clinical remission induced by synthetic and biological modifying disease drugs.
    Cruces M; Al Snih S; Serra-Bonett N; Rivas JC
    Reumatol Clin (Engl Ed); 2019; 15(4):218-222. PubMed ID: 29032909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of Doppler ultrasound synovitis versus clinical synovitis with changes in native complement component levels in rheumatoid arthritis patients treated with biologic disease-modifying anti-rheumatic drugs.
    Montoro Alvarez M; Chong OY; Janta I; González C; López-Longo J; Monteagudo I; Valor L; Garrido J; Lau IS; Rosman A; Naredo E; Carreño L
    Clin Exp Rheumatol; 2015; 33(2):141-5. PubMed ID: 25665178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.
    Brown AK; Quinn MA; Karim Z; Conaghan PG; Peterfy CG; Hensor E; Wakefield RJ; O'Connor PJ; Emery P
    Arthritis Rheum; 2006 Dec; 54(12):3761-73. PubMed ID: 17133543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical synovitis and tenosynovitis by ultrasonography (US) 7 score in patients with rheumatoid arthritis treated with synthetic drugs, in clinical remission by DAS28.
    Ventura-Ríos L; Sánchez Bringas G; Hernández-Díaz C; Cruz-Arenas E; Burgos-Vargas R
    Reumatol Clin (Engl Ed); 2019; 15(5):e5-e9. PubMed ID: 29198500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion of Synovial Tissue-Derived Characteristics in a Nomogram for the Prediction of Treatment Response in Treatment-Naive Rheumatoid Arthritis Patients.
    Alivernini S; Tolusso B; Gessi M; Gigante MR; Mannocci A; Petricca L; Perniola S; Di Mario C; Bui L; Fedele AL; Capacci A; Bruno D; Peluso G; La Torre G; Federico F; Ferraccioli G; Gremese E
    Arthritis Rheumatol; 2021 Sep; 73(9):1601-1613. PubMed ID: 33750008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
    Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
    Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current immunotherapy in rheumatoid arthritis.
    Meier FM; Frerix M; Hermann W; Müller-Ladner U
    Immunotherapy; 2013 Sep; 5(9):955-74. PubMed ID: 23998731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core management principles in rheumatoid arthritis to help guide managed care professionals.
    Agarwal SK
    J Manag Care Pharm; 2011; 17(9 Suppl B):S03-8. PubMed ID: 22073933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics associated with drug-free sustained remission in patients with rheumatoid arthritis: Data from Korean Intensive Management of Early Rheumatoid Arthritis (KIMERA).
    Jung SM; Pyo JY; Lee SW; Song JJ; Lee SK; Park YB
    Semin Arthritis Rheum; 2020 Dec; 50(6):1414-1420. PubMed ID: 32241617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis.
    Forslind K; Svensson B
    Scand J Rheumatol; 2016; 45(2):99-102. PubMed ID: 26313244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review.
    Giollo A; Bissell LA; Buch MH
    Expert Opin Drug Saf; 2018 Jul; 17(7):697-708. PubMed ID: 29871535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid arthritis: a clinical overview of new diagnostic and treatment approaches.
    Sanmartí R; Ruiz-Esquide V; Hernández MV
    Curr Top Med Chem; 2013; 13(6):698-704. PubMed ID: 23574518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic rheumatoid arthritis therapies: do we need more comparative effectiveness data?
    Levesque MC
    BioDrugs; 2012 Apr; 26(2):65-70. PubMed ID: 22385403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of leucocyte immunoglobulin-like receptor expression in the synovium of rheumatoid arthritis patients after treatment with disease-modifying anti-rheumatic drugs.
    Huynh OA; Hampartzoumian T; Arm JP; Hunt J; Borges L; Ahern M; Smith M; Geczy CL; McNeil HP; Tedla N
    Rheumatology (Oxford); 2007 May; 46(5):742-51. PubMed ID: 17202177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-TNF treatment in rheumatoid arthritis.
    Geiler J; Buch M; McDermott MF
    Curr Pharm Des; 2011; 17(29):3141-54. PubMed ID: 21864263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
    Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH
    Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.